微生物组衍生代谢物三甲基胺N-氧化物与慢性病风险相关

Junyi Jiang1,2, Peng Zhu1, Xiaoying Ding3

  • 1Engineering Research Center of Applied Technology of Pharmacogenomics (Ministry of Education, China), Hunan Key Laboratory of Pharmacomicrobiomics, Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, 410008, People's Republic of China.

概括

高水平的三甲基胺N氧化物 (TMAO) 与慢性病 (CKD) 的风险增加有关. 这种代谢物在区分CKD方面表现出适度的能力,年龄,性别和BMI可能会影响这种关联.